Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

2.68
Delayed Data
As of Aug 28
 +0.07 / +2.68%
Today’s Change
1.38
Today|||52-Week Range
4.10
+17.03%
Year-to-Date
No recent news for OncoGenex Pharmaceuticals Inc.

Today’s Trading

Previous close2.61
Today’s open2.52
Day’s range2.51 - 2.84
Volume826,080
Average volume (3 months)879,512
Market cap$79.8M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+33.18%
Earnings growth (this year)+40.69%
Earnings growth (next 5 years)--
Revenue growth (last year)-9.26%
P/E ratioNM
Price/Sales1.53
Price/Book1.78

Competitors

 Today’s
change
Today’s
% change
CNATConatus Pharmaceutic...+0.37+10.05%
AVEOAveo Pharmaceuticals...+0.02+1.43%
OGENOragenics Inc-0.12-5.13%
PULMPulmatrix Inc+0.13+2.36%
Data as of 4:01pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$27.1M
Annual profit (last year)-$26.2M
Net profit margin-96.77%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary, Treasurer &
Director
Scott Daniel Cormack
Chief Financial Officer &
Vice President
John A. Bencich
Corporate headquarters
Bothell, Washington

Forecasts

Partner Offers